RecruitingNCT07258329
Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
Screening Della Compromissione Fetale Intrapartum Mediante Utilizzo Dei Marcatori Placentari
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
428 participants
Start Date
Mar 28, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1/PlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- Age ≥ 18 years
- Gestational age ≥ 32 weeks
- Obtaining informed consent for participation in the study and for the processing of personal data
- Pregnant patients with an indication to perform placental marker testing as part of routine clinical practice
- Patients who will deliver at the Obstetrics Units of the participating centers
Exclusion Criteria1
- \- Absolute contraindications to vaginal delivery (placenta previa, vasa previa, placenta accreta, previous myomectomy)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07258329
Related Trials
Outpatient Induction of Labour Using a Double Balloon Transcervical Catheter in Low-risk Pregnant Women: a Two-centre Open Prospective Randomised Controlled Trial - OutCRIB
NCT072655182 locations
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
NCT054465711 location
Effect of Helfer Skin Tap and Cold Application on Pain and Hemodynamics During Vaccination
NCT069766321 location
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT065235431 location
Prevention of Stretch Marks in Expectant Mothers
NCT074678371 location